Evaluation of the Association Between DNA Methylation and Shortened Survival in Patients With Advanced Colorectal Cancer Treated With 5-FU/Oxaliplatin-Based Regimens in E3200.

Trial Profile

Evaluation of the Association Between DNA Methylation and Shortened Survival in Patients With Advanced Colorectal Cancer Treated With 5-FU/Oxaliplatin-Based Regimens in E3200.

Completed
Phase of Trial: Phase III

Latest Information Update: 18 Jun 2014

At a glance

  • Drugs Bevacizumab (Primary) ; Carboplatin; Fluorouracil; Folinic acid; Irinotecan; Oxaliplatin; Paclitaxel
  • Indications Colorectal cancer
  • Focus Therapeutic Use
  • Most Recent Events

    • 09 May 2009 New source identified and integrated (ClinicalTrials.gov record NCT00897754).
    • 28 Jan 2008 Broad-label approval was based on the results of this study and NO16966 [see 700003183].
    • 26 Apr 2007 Status change
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top